Stock screenerAll disclosures →
EDGAR →
VRTX
Conviction 75HealthcareScan · Mon, Jul 20, 2026Bearish engulfing
VRTX$480.67-1.03%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
2
Vol MA14 1.66M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price480.67
Change-1.03%
Gap+0.31%
Rel volume1.04×
Avg volume2.01M
Avg $ vol990.95M
SMA 20491.13
SMA 50460.97
SMA 200449.76
Price vs 50+4.27%
Price vs 200+6.87%
MA stackbullish
50/200 cross—
Supertrenddown · 519.77
RSI (14)51
MACD hist-4.09
MACD crossbear · 6d
Stoch %K / %D17 / 23
ADX (14)27
+DI / −DI25 / 19
RSI divergence—
MACD divergence—
ATR %+2.92%
ADR %2.97%
52w high529.59
52w low366.54
From 52w high-9.24%
Above 52w low+31.14%
New 52w highNo
SqueezeOff
Bollinger width14.41%
%B0.35
Donchian pos34.13%
Donchian high533.67
Donchian low453.21
AVWAP (52w high)493.13
vs AVWAP high-2.53%
AVWAP (52w low)441.73
vs AVWAP low+8.81%
OBV trendUp
Chaikin MF (20)0.06
Today vs 20d1.04×
Avg vol (14d)1.66M
Avg vol (20d)2.01M
Avg $ vol (20d)990.95M
Market cap122B
RS 3m (vs SPY)+5.54%
RS 6m (vs SPY)+0.37%
RS line new highNo
Trend template8/8
Technical rank72.4
1 week+0.09%
1 month+4.72%
3 months+8.95%
6 months+9.51%
1 year+3.76%
YTD+6.31%
P/E30.86
P/B6.30
P/S10.17
P/FCF38.20
EPS15.32
Div yield—
ROE20.42%
ROA14.93%
Debt/Eq0.01
Current3.02
EV/EBITDA26.60
Gross margin—
Net margin32.94%
Rev growth8.90%
EPS growth838.09%
Price target558.30
Target upside16.15%
Analyst ratingBuy
Institutional104.60%
Ent. value116.61B
Revenue2.99B
Net income1.03B
Gross profit—
Free cash flow3.19B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out253.81M
Employees6.4K
ListedWed, Jul 31, 1991
Free float253.88M
Float %99.8%
Short interest4.94M
Days to cover2.0d
Short volume47.9%
Squeeze score20 / 100
Next earningsMon, Aug 3, 2026 · after (14d)
EPS forecast$4.25 · 6 est
Last EPS vs est$3.95 vs $3.69
Last surprise+7.0% beat
Setup gradeA
Conviction75 / 100
Pattern quality—
Tech rank72.4 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish engulfing
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VRTX · 9 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
David J. Taylor house · R · OH · traded 2025-08-07 | Buy | $1K–$15K | 2025-08-07 | 2025-09-02 | |
Lisa McClain house · R · MI · traded 2024-12-11 | Buy | $1K–$15K | 2024-12-11 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-11 | Sell | $1K–$15K | 2025-06-11 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-10 | Sell | $1K–$15K | 2025-06-10 | 2025-08-13 | |
Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 | |
Byron Donalds house · R · FL · traded 2025-03-20 | Sell | $1K–$15K | 2025-03-20 | 2025-04-14 | |
Jefferson Shreve house · R · IN · traded 2025-03-13 | Buy | $15K–$50K | 2025-03-13 | 2025-04-11 | |
Jefferson Shreve house · R · IN · traded 2025-02-24 | Buy | $15K–$50K | 2025-02-24 | 2025-03-09 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2024-06-14 |
Insider activity
SEC Form 4 transactions in VRTX · 2 buys · 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SACHS BRUCE I Director · Deferred Stock Units · 2026-07-15 | Grant | 99.941 | $47K | 2026-07-15 | 2026-07-17 |
Garber Alan M Director · Deferred Stock Units · 2026-07-15 | Grant | 31.56 | $15K | 2026-07-15 | 2026-07-17 |
McKechnie Duncan EVP, Chief Commercial Officer · Common Stock · 2026-07-02 | Sell | 1.54K | $800K | 2026-07-02 | 2026-07-07 |
Tatsis Ourania EVP, Chief Reg. & Quality Off. · Common Stock · 2026-07-02 | Sell | 1.5K | $787K | 2026-07-02 | 2026-07-07 |
Bozic Carmen EVP and CMO · Common Stock · 2026-06-26 | Sell | 596 | $288K | 2026-06-26 | 2026-06-30 |
Bozic Carmen EVP and CMO · Common Stock · 2026-06-15 | Sell | 4.06K | $1.8M | 2026-06-15 | 2026-06-17 |
Bozic Carmen EVP and CMO · Common Stock · 2026-06-05 | Sell | 1.75K | $785K | 2026-06-05 | 2026-06-09 |
Liu Joy EVP and Chief Legal Officer · Common Stock · 2026-06-01 | Sell | 828 | $364K | 2026-06-01 | 2026-06-03 |
Bozic Carmen EVP and CMO · Common Stock · 2026-05-29 | Sell | 1.97K | $888K | 2026-05-29 | 2026-06-02 |
Bunnage Mark E. EVP, Chief Scientific Officer · Common Stock · 2026-05-15 | Sell | 33 | $15K | 2026-05-15 | 2026-05-19 |
SEC filings
EDGAR filings in VRTX · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.